ABUS vs PPG · P/E 5.4, rev $6.2M vs P/E 17, rev $15.88B
Arbutus Biopharma Corp (ABUS) versus PPG Industries Inc (PPG) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
PPG Industries Inc (PPG) is a specialty chemicals company listed on NYSE.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported PPG revenue for 2025-12-31 was $15.88B. Net income was $1.58B. Revenue was up 0.2% from 2024-12-31 to 2025-12-31. PPG currently screens at market cap $26.11B and trailing P/E 16.8.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. PPG currently screens at market cap $26.11B and trailing P/E 16.8.
Not investment advice. Open the ABUS and PPG stock pages for the full models.
Not investment advice.